Eli Lilly and Company Stock Price and Value Analysis

Should you buy Eli Lilly and Company stock? (NYSE:LLY). Let's see how it does in our automated value investing analysis system.

LLY Free Cash Flow Trend

Free Cash Flow trendline for LLY
Free Cash Flow trendline for Eli Lilly and Company

Based on historical returns, we believe that Eli Lilly and Company can grow its free cash at a rate of about 3%. That's positive!

  • This company is very stable.
  • This company has an average dividend yield.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This stock looks overpriced.

Inside the LLY Numbers

LLY Price
(Eli Lilly and Company stock price per share)
[?] LLY Fair Price
(based on intrinsic value)
[?] LLY Safety Price (based on a variable margin of safety) $26.24
[?] PE Ratio versus Sector 20% lower than other Healthcare stocks
[?] PE Ratio versus Industry 5% lower than other Drug Manufacturers - Major stocks
[?] Cash Yield 2.44%
[?] Free Cash Flow Jitter 64%
[?] Dividend Yield 2%

Is Eli Lilly and Company Stock on Sale?

We believe that Eli Lilly and Company may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Eli Lilly and Company looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy LLY Stock?

Does Eli Lilly and Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.